Trial Results Search
Clinical Trial Results: Mircera [methoxy polyethylene glycol-epoetin beta]
-
Protocol Number: ML20338
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.08.2008
Phase: III
-
Protocol Number: ML20337
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.09.2008
Phase: III
-
Protocol Number: BH17847
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.05.2009
Phase: III
-
Protocol Number: BA17283
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: BA16740
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: BA17284
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: BA16739
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: ML22014
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25300
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia
-
Protocol Number: ML25276
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25289
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22916
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: II
A Study of Mircera in Patients With Chronic Kidney Disease (PRIMAVERA)
-
Protocol Number: ML22299
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: MH21299
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 14.12.2007
Phase: IV
-
Protocol Number: ML25754
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25067
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25368
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25465
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25317
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22643
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22714
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25476
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25617
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML25701
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: BA16528
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 26.05.2005
Phase: II
-
Protocol Number: BA16260
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.02.2006
Phase: II
-
Protocol Number: BA16285
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: II
-
Protocol Number: BA16286
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: II
-
Protocol Number: BA16736
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: BA16738
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: 01.03.2006
Phase: III
-
Protocol Number: ML28145
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
-
Protocol Number: ML22911
Product Name: Mircera [methoxy polyethylene glycol-epoetin beta]
Date of Report: To be Published
Phase: IV
Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine
About This Database
This database is populated with information on the results of Roche-sponsored clinical trials.